A study conducted by Dr Katherine Tucker a nutritional epidemiologist at the Jean Mayer U.S
Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling
all other human data consists of small open-label studies or observational reports from underground fitness communities
In the case of animals inoculated peripherally with scrapie, the agent propagates along peripheral sensory and autonomic nerves in the peritoneum to enter the spinal cord and medulla, and then ascends to invade the brain (Kimberlin and Walker, 1982)
Its oral bioavailability is approximately 50%, and it reaches peak plasma concentration within 3 to 4 hours of dosing [1]
Muscle loss concerns: Research shows that roughly one-quarter to one-third of weight lost on GLP-1 agonists comes from lean body mass rather than fat